Lv51
810 积分 2024-05-10 加入
A bispecific antibody that targets the membrane-proximal region of mesothelin and retains high anticancer activity in the presence of shed mesothelin
3个月前
已完结
Tumor-Targeted Delivery of IL-2 by Fusing with a pH Low Insertion Peptide for Antitumor Immunotherapy
4个月前
已完结
Cancer therapy with antibodies
5个月前
已完结
Engineering interferons and interleukins for cancer immunotherapy
7个月前
已完结
Strategies to therapeutically modulate cytokine action
7个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
7个月前
已完结
The present and future of bispecific antibodies for cancer therapy
9个月前
已完结
皖公网安备34019202002308
